Advertisement

Topics

Glycorex Transplantation AB Company Profile

21:22 EDT 18th June 2018 | BioPortfolio

Glycorex Transplantation AB (publ.) markets products that decrease the risk of graft-rejection. The products facilitate an increased number of transplants.The company was founded in 1996 by Dr. Kurt Nilsson and is located in Lund in southern Sweden.
The company market products enabling an increased number of transplants. The products are clinically used enabling ABO-incompatible transplants at several European transplant centers.

Location

Solvegatan 41
Lund
223 70
Sweden

Contact

Phone: 046-286 57 80
Fax: 046-286 57 81
Email: glycorex.transplantation@glycorex.ideon.se


News Articles [228 Associated News Articles listed on BioPortfolio]

Decreasing Incidence of Cancer After Liver Transplantation

A decades-long study found a decrease in cancer risk after liver transplantation. What factors may have contributed to the decline? American Journal of Transplantation

[News] Source of stem cells in haploidentical transplantation

The use of peripheral blood stem cells (PBSCs) as the stem cell source in patients with acute leukaemia undergoing haploidentical transplantation with post-transplantation cyclophosphamide does not ch...

Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation

Penis Transplantation: First US Experience

What lessons have been learned from the first successful case of penile transplantation in the United States? Annals of Surgery

Sleeve gastrectomy with liver transplantation improves outcomes for obesity

Simultaneous liver transplantation and sleeve gastrectomy improved weight loss and led to decreased rates of metabolic complications among obese patients compared with liver transplantation alone, acc...

Release of the first textbook on blood and marrow transplantation for nurses

(European Society for Blood and Marrow Transplantation) This is the first book specifically written by and for nurses with an interest in Hematopoietic Stem Cell Transplantation (HSCT). It offers the ...

Blood or marrow transplantation survivors have higher risk of cognitive impairment

Allogeneic blood or marrow transplantation recipients are at a significantly higher risk of cognitive impairment in the years post-transplantation, according to a study published in Journal of Clinica...

Early Liver Transplantation for Severe Alcoholic Hepatitis

Early transplantation was associated with over 80% survival by the 3-year mark.

Drugs and Medications [36 Associated Drugs and Medications listed on BioPortfolio]

Mycophenolate mofetil [Ascend Laboratories, LLC]

Mycophenolate Mofetil Tablets USP 500 mg

Iv busulfex(busulfan) injection [ESP Pharma, Inc.]

IV Busulfex(busulfan) Injection

Simulect [Novartis Pharmaceuticals Corporation]

T2005-28 2027722        Simulect         (basiliximab)       For Injection       Rx only       Prescribing Information

Nulojix [E.R. Squibb & Sons, L.L.C.]

These highlights do not include all the information needed to use NULOJIX safely and effectively. See full prescribing information for NULOJIX. NULOJIX (belatacept)For injection, for intravenous use I...

Clotrimazole [Physicians Total Care, Inc.]

PubMed Articles [1553 Associated PubMed Articles listed on BioPortfolio]

Islet transplantation as safe and efficacious method to restore glycemic control and to avoid severe hypoglycemia after donor organ failure in pancreas transplantation.

The aim of this study was to assess safety and efficacy of islet transplantation after initial pancreas transplantation with subsequent organ failure. Patients undergoing islet transplantation at our ...

Teaching a Young Dog New Tricks: Modifications to the Post-Transplantation Cyclophosphamide Haploidentical Transplantation Platform.

Impact of a first study of early transplantation in acute alcoholic hepatitis: Results of a nationwide survey in French liver transplantation programs.

Electrocardiographic changes before and after successful kidney transplantation and associations with cardiovascular and mortality outcomes.

Electrocardiographic (ECG) changes before and after kidney transplantation are not well-defined. Our aim was to describe the evolution of ECG in patients on dialysis before and after successful kidne...

CMV infection in heart transplantation: A single center experience.

CMV infection remains a major complication after heart transplantation with varying prophylaxis strategies employed. We sought to determine the impact of valganciclovir (VGC) duration on the epidemiol...

Clinical Trials [2753 Associated Clinical Trials listed on BioPortfolio]

Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection

To show the feasibility of liver transplantation in HCV-HIV coinfected patients. To study the two-year survival after transplantation, the interaction between HCV and HIV after transplanta...

Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation

The objective of this trial is to assess the toxicity of thymus transplantation following unrelated umbilical cord blood transplantation. Emphasis will be placed on adverse events that ar...

Cranoc Lipid Study in Renal Transplantation

Cardiovascular disease after renal transplantation is an important problem. Patients after renal transplantation with low LDL-Levels (

Uterus Transplantation From a Multi-organ Donor

Uterus transplantation: screening, in vitro fertilization [IVF] treatment to be able to freeze embryos, uterus transplantation, pregnancy and afterwards removal of the uterus.

Evaluation of a New Regional Organization to Promote Access to Renal Transplantation

Patients with terminal chronic kidney disease (CRD) need renal function supplementation, namely dialysis or renal transplantation. Transplantation is the most efficient and cost-effective ...

Companies [143 Associated Companies listed on BioPortfolio]

Glycorex Transplantation AB

Glycorex Transplantation AB (publ.) markets products that decrease the risk of graft-rejection. The products facilitate an increased number of transplants.The company was founded in 1996 by Dr. Kurt N...

Glycorex

Glycorex in the forefront of glycobiology. a partner in the development of carbohydrate based therapeutics and a unique supplier of high quality carbohydrates. custom synthesis.

American Society of Transplantation (AST)

The American Society of Transplantation (AST) is an international organization of transplant professionals who are dedicated to advancing the field of transplantation and improvin...

National Institute of Transplantation

The National Institute of Transplantation is an internationally recognized leader in all scientific areas of organ transplantation including laboratory and clinical research as well as professional an...

American Society of Transplantation

The American Society of Transplantation (AST) is an international organization of transplant professionals who are dedicated to advancing the field of transplantation and improvin...

More Information about "Glycorex Transplantation AB" on BioPortfolio

We have published hundreds of Glycorex Transplantation AB news stories on BioPortfolio along with dozens of Glycorex Transplantation AB Clinical Trials and PubMed Articles about Glycorex Transplantation AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Glycorex Transplantation AB Companies in our database. You can also find out about relevant Glycorex Transplantation AB Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...


Corporate Database Quicklinks



Searches Linking to this Company Record